相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Managing Central Nervous System Spread of Lung Cancer: The State of the Art
David Chun Cheong Tsui et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
Sai-Hong Ignatius Ou et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer
Joshua K. Sabari et al.
CLINICAL CANCER RESEARCH (2022)
Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer
Jarrett J. Failing et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
E. Felip et al.
ANNALS OF ONCOLOGY (2021)
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah et al.
CLINICAL CANCER RESEARCH (2021)
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial
Rudolf M. Huber et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma
David J. H. Shih et al.
NATURE GENETICS (2020)
Contraction of T cell richness in lung cancer brain metastases
Aaron S. Mansfield et al.
SCIENTIFIC REPORTS (2018)
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer
A. S. Mansfield et al.
ANNALS OF ONCOLOGY (2016)
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer
Shirish M. Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases
Paul K. Paik et al.
CANCER DISCOVERY (2015)
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
Shirish M. Gadgeel et al.
LANCET ONCOLOGY (2014)